VZV

Clinical trials for VZV explained in plain language.

Never miss a new study

Get alerted when new VZV trials appear

Sign up with your email to follow new studies for VZV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New shingles vaccine candidate enters Mid-Stage trial

⭐️ VACCINE ⭐️ Ongoing

This study tests a new shingles vaccine called LYB004 in 840 adults aged 40 and older in China. Participants receive one of four different doses of the vaccine or a placebo. The goal is to see how well the vaccine triggers an immune response and whether it is safe.

Matched conditions: VZV

Phase: PHASE2 • Sponsor: Guangzhou Patronus Biotech Co., Ltd. • Aim: ⭐️ VACCINE ⭐️

Last updated Jun 27, 2026 08:07 UTC

VZV

Get alerted when new VZV trials appear

New shingles vaccine candidate enters Mid-Stage trial